Failed ISCHEMIA Trial or Failed Ischemia Testing?

Suraj Dahal, Matthew J Budoff1

  • 1Professor of Medicine, UCLA School of Medicine, Program Director, Division of Cardiology, Director, Cardiac CT Laboratory, Lundquist Institute at Harbor-UCLA Medical Center, 1124 W. Carson Street, Torrance, CA 90502 USA. mbudoff@lundquist.org.

Insights

The ISCHEMIA trial found invasive therapy did not reduce major adverse cardiac events compared to optimal medical therapy for stable ischemic heart disease. Better revascularization guidance may improve outcomes in future studies.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Stable ischemic heart disease (SIHD) affects millions globally.
  • Optimal medical therapy (OMT) is the standard of care for SIHD.
  • The role of invasive therapy in SIHD remains a subject of investigation.